Skip to main content
. 2025 Nov 4;15:38455. doi: 10.1038/s41598-025-91777-4

Table 2.

Chemotherapeutics used before and during BMT.

Variables Study cases (N = 25)
N %
Chemotherapeutics before BMT
 Cyclophosphamide 18 72

 Doxorubicin

Total cumulative dose (mg/m 2 )

15

300 ± 93*

60
 Cyclophosphamide + Doxorubicin 9 36
Chemotherapeutics during BMT

 Cyclophosphamide

Total cumulative dose (g/m 2 )

5

15.5 ± 2.3*

20
 Busulfan 16 64
 Melphalan 20 80
 Carmustine 9 36

N: number. Categorical data expressed as Number (%)continuous variables : mean ± standard deviation.